StockData
Collegium Pharmaceutical, Inc logo

Collegium Pharmaceutical, Inc (COLL) income statement

COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3047% below fair value
$25.93+0.38 (+1.49%)

Close on Nov 18, 2026Market cap $844.17MP/E 20.9Yield –

Collegium Pharmaceutical, Inc financial ratios

See a number that looks wrong?